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Herein is a described a novel robotic system which is the first system using intraoperative prostate motion 
tracking and MRI-TRUS fusion to guide needles into the prostate. Its use is dedicated to brachytherapy, 
focal therapy and transperineal prostate biopsies.  
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ABSTRACT 
Purpose: To report on the initial experience with a new 3D ultrasound robotic system for prostate 
brachytherapy assistance, focal therapy and prostate biopsies. Its ability to track prostate motion intra-
operatively allows it to manage motions and guide needles to predefined targets.  
Materials and methods: A robotic system for TRUS-guided needle implantation combined with 
intraoperative prostate tracking was created. Experiments were conducted on 90 targets embedded in 9 
mobile and deformable synthetic prostate phantoms. The experiments involved trying to insert glass beads 
as close as possible to targets in multimodal anthropomorphic imaging phantoms. The results were 
measured by segmenting the inserted beads in CT scan volumes of the phantoms.  
Results: The robot was able to reach the chosen targets in phantoms with a median accuracy of 2.73 mm, 
with a median prostate motion of 5.46 mm. Accuracy was better in apex than in base (2.28 vs 3.83 mm, 
p<0.001) and was similar for horizontal and angled needle inclinations (2.7 vs 2.82 mm, p=0.18).  
Conclusion: This robot for prostate focal therapy, brachytherapy and targeted prostate biopsies is the first 
system using intraoperative prostate motion tracking to guide needles into the prostate. The preliminary 
experiments described show its ability to reach targets in spite of the motion of the prostate.  
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INTRODUCTION 
Numerous methods exist for treating localized prostate cancer. Among these, radical prostatectomy, 
external beam radiotherapy and prostate brachytherapy are considered standard treatments, while focal 
therapies such as focal cryotherapy and photodynamic therapy, although more recent, have been shown to 
have the potential to improve functional outcomes after treatment of a localized cancer 1, 2. Except HIFU, 
most of these treatments use implanted needles. Brachytherapy and ablative treatments use a template to 
insert the needles along a grid of horizontal holes, the depth of each needle being adjusted visually using 
2D trans-rectal ultrasound (TRUS) guidance. Limitations to this implantation technique may exist. Both 
the insertion of the needles and the movement of the probe cause significant motion and deformation of 
the prostate 3, which could cause implantation inaccuracies. Needle insertion is also restricted to the 
template’s horizontal axis, thereby restricting access behind the pubic arch and limiting eligibility to 
patients with prostates < 60 cm3 4, 5. 
We propose a computer-assisted robotic system called PROSPER, that consists of a robotic needle 
insertion device and a static 3D ultrasound probe6-8 (Figure 1). The robot allows needles to be inserted 
whatever the implanted angles, prostate size and prostate mobility, hence improving implantation 
accuracy, allowing for targeting of tumor foci and extending the indications for larger prostates. Although 
focal therapy is the long term goal for the system, brachytherapy was chosen as the first application 
because of the current lack of long term data concerning focal therapy9. This device could also be 
available for multiparametric prostate biopsies. 
This paper presents the robot characteristics and procedure. We report the results of tests to assess the 
accuracy of needle insertion in prostate phantoms.   
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MATERIALS AND METHODS 
ROBOT DESIGN  
The robotic needle manipulator consists of a needle holder that is mounted on the lateral side of the US 
probe. It positions the needle along the appropriate insertion axis and drives it to a given depth. The robot 
uses seven motors, giving it seven degrees of freedom (figure 2).  To increase safety, a mechanical release 
system disengages the needle from the robot in case the latter comes in contact with the pubic bone. The 
needle guide at the front of the needle insertion module and the bushing holding the needle are sterilizable. 
The rest of the robot is covered by a sterile plastic cap. The robot has been designed and developed by our 
group and described in detail in a previous paper6. 
 
CLINICAL PROCEDURE DESCRIPTION 
An Ultrasonix™ 4DEC9-5 end-fire 3D probe is connected to an Ultrasonix RP™ machine.   
The robotic needle manipulator is rigidly calibrated pre-operatively to the probe placed in the rectum. A 3D 
US reference volume is acquired. The needle trajectories and seed positions are then defined with respect to 
the reference prostate, according to the expected planning. 
 The robot positions the needle-holder in front of the perineum and inserts the first needle.  In case of 
pubic arch interference, the needle is withdrawn and a partial re-planning is done to modify the needle 
trajectory in order to avoid the pubic arch.  Once the needle has been inserted to its planned position, a 
verification procedure is applied to check for any prostate motion or deformation caused by the insertion.  
This is done by taking a second 3D US volume and registering it with the reference volume. If the target is 
not reached, the needle depth is adjusted iteratively until the expected point is reached. The treatment is 
applied, and the procedure is repeated for the rest of the needles. 
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PHANTOM TESTS 
 We performed a set of simulated procedures by depositing glass beads through inserted needles into 
realistic, mobile synthetic prostate phantoms.  The results were measured by segmenting the inserted beads 
in CT scan volumes of the phantoms. Glass beads were chosen instead of titanium seeds because of the 
absence of artifacts in the CT images. 
We developed the phantoms to obtain realism in US, CT and MRI images, but also in the mechanical 
soft-tissue behavior during needle insertion. The phantoms were built of soft PVC plastic, and included a 
hard perineum, soft peri-prostatic region, a harder prostate with an echogenic capsule and a hollow rectum 
for probe insertion.  The differences in elasticity of the various anatomical regions made for realistic needle 
insertion forces and prostate motions.  The prostate was molded with ten 1mm diameter glass beads 
embedded inside, acting as targets for needle insertion. The US probe was inserted into the phantom’s 
rectum, giving realistic images of the prostate, with the glass targets being easily segmented. The phantom 
and its targets could also be seen clearly in CT images, allowing us to verify placement in CT volumes 
(figure 3).  A detailed description of the phantoms has been published elsewhere 10. 
The experiment conducted with the PROSPER system involved trying to insert needles as close as 
possible to 90 targets embedded in 9 phantoms. As this study is an exploratory trial, no validated 
information on the effect of size and on the variability of needle accuracy was available, thus the sample 
size had no statistical rationale. We planned initially to construct 10 phantoms, each with 10 target beads 
embedded inside. Unfortunately, given the complexity of building an anthropomorphic synthetic prostate 
phantom, one phantom was damaged and was not available for the study.  
The experimental procedure was as follows: the targets were segmented in a reference 3D US image and 
their coordinates were sent to the robot, which proceeded to insert the respective needle accordingly.  An 18 
gauge Mick Ripple-Hub™ needle was used, with an insertion speed of 5mm/s and a rotation speed of 8rps. 
Needle rotation is known to decrease needle-tissue forces, needle bending and tissue deformation 11. Once 
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the needle was inserted, a second US volume was acquired and the initial reference volume registered to it.  
The new deformed target location was sent back to the robot. Then, it adjusted the needle depth to the 
closest point along the needle axis to this new target location.  This was repeated until no further depth 
change could be made.  A glass bead was then deposited through the hollow needle to mark the needle’s 
final position. 
Targets that were near the superior surface of the prostate were approached at a 10˚ horizontal and vertical 
inclination to simulate pubic arch avoidance.  The phantoms were then imaged in a Philips™ Brilliance 64 
CT scanner at a scanning resolution of 0.15 x 0.15 mm per pixel and 0.33 mm slice spacing.  The target and 
inserted beads were segmented and the distance between them was measured. Data were presented as 
median and interquartile range. Phantom coordinates were categorized into locations (anterior-posterior, 
right- left-central zone). Comparison of the accuracy according to the locations was performed using a 
Mann-Whitney U test or a Cruskal-Walis test as appropriate with PASW v18 (SPSS Inc, Chicago,Il). 
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RESULTS 
 In the phantom experiments, at the apex, the median distance between the centers of the target and 
inserted beads was 2.28mm, while at the base it was 3.83mm (p<0.001). The more the targets were on the 
left, the higher the error was (2.2 vs 3.6 mm, p=0.002). The median amount by which the target moved in 
the needle insertion direction after image registration was 4.0 mm at the apex and 6.5 mm at the base of the 
prostate (median 5.46 mm, IQR 3.77-6.71). This can be understood as the amount of prostate motion in the 
needle-insertion direction.  A large majority of the targets required one single depth correction to reach the 
final insertion point, while about 5% required two or more corrections. Accuracy was not different between 
horizontal and angled needle inclinations (2.7 vs 2.82 mm, p=0.28) and between anterior and posterior 
locations (2.7 vs 2.7 mm, p= 0.59). The maximum corrections provided by the tracking system were found 
in left (7.1 mm), base (6.5 mm) and posterior locations (5.9 mm) (table 1). Homogeneous motions of the 
prostate were detected by the tracking algorithm in all three spatial directions, x, y and z. This suggested, 
not just prostate translation in the needle direction (z), but also prostate rotation, that was accentuated with 
the depth of the needle (punctures at the base provide a bigger motion than those at the apex, whatever the 
axis considered) (table 2). 
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DISCUSSION 
An important aspect for successful transperineal needle-based interventions is the ability to track prostate 
motion intra-operatively. Deformations and motions are highly underestimated in conventional practice. 
Artignan et al. estimated that the prostate moved by at least 5 and 3 mm respectively in a sagittal and 
coronal plane, related only to the probe insertion 12. Moreover, according to Roy, needle insertion could 
result in motions of the base of the prostate of up to 15 mm 13. It has been stated in the literature that the 
primary axis of prostate mobility during an insertion is along the needle insertion axis 14.  Our experiments 
confirmed that prostate rotation can also affect the results: the deeper is the insertion, the more the prostate 
rotated.  It was also noticed that peripheral needles caused more rotation than central needles, as could be 
expected, if the prostate is assumed to be constrained by the pubo-prostatic ligaments.   
Clinical outcomes of this imprecision may be negligible in a treatment of the whole gland like for 
brachytherapy, but they may be more serious in focal therapy or targeted biopsies. 
The results described above show that in our synthetic phantoms, needle insertion caused significant 
motion, on the order of 5mm in the direction of the needle axis.  Without the registration step, the resulting 
seed distribution would have been significantly offset from the planned distribution.  By correcting the 
needle depth based on the prostate motion, the accuracy of the system in the needle insertion direction was 
measured to be 2.28 mm at the apex and a little more (3.83 mm) at the base due to poorer image resolution 
at greater depths. The experiments showed that the system was capable of drastically reducing the errors 
caused by prostate mobility in the cranial-caudal direction. This was true for the different depths of 
insertion and approach angles tested.  
We defined optimal needle insertion and rotation speed according to a needle insertion force study 
previously published6. In the phantom (similarly to in vivo force measurements reported in the literature 
during live brachytherapy)15, the maximal force (1.8N) was reached when traversing the perineum. The 
amount of prostate motion was minimal with an insertion speed of 5mm/s. Although this speed is lower 
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than during a manual procedure, it allows a safe insertion. Indeed, the insertion can be interrupted at any 
time by pressing the emergency stop button. 
The reason why the robot is less precise when targeting to the left of the prostate is unclear. A possible 
explanation is that the weight of the robot might create increased gravitational strain on the robot causing a 
curvature towards the left side and thus a lower accuracy. This will have to be improved in the upcoming 
version of the robot.  
The accuracy results are hardly comparable with systems previously described. Indeed, PROSPER is the 
only robot providing a motion tracking system and angulated needle insertion. As a result it could improve 
pubic collision avoidance, providing a better access to anterior and lateral parts of the prostate and 
extending the indications for larger prostates16.  
Conceptually, focal therapy has the potential to minimize treatment-related toxicity without 
compromising cancer-specific outcome 2. A current limitation to the proliferation of focal therapy as a 
viable treatment option is the inability to stage or grade the cancer accurately because of suboptimal 
imaging capabilities. In the near future, there is no doubt that imaging will detect better cancer foci, 
especially those with high probability to develop 17. As shown in recent studies, multiparametric MRI 
makes it possible to predict more accurately the location of tumor foci particularly those with high grade 18. 
We believe that MR imaging could improve the efficiency of focal therapy and obviously prostate biopsies. 
MRI guidance is a challenging task due to the need of MR compatible instruments and the difficulty to 
process images in real time. In contrast, MRI-TRUS fusion has the advantage of combining pre-operative 
MR images and intra-operative ultrasound images in a real-time display19, 20.  
The robot described herein is an attempt at a multimodality robot that could combine the accuracy of 
robotic needle guidance, precise tracking of prostate motions and deformations as well as MRI-TRUS 
fusion for facilitated target detection and intervention planning. Indeed, PROSPER is coupled to a MRI-
TRUS fusion algorithm. A 3D US reference volume is acquired then registered to a pre-operative MRI 
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acquisition to facilitate and improve prostate delineation, initial dose planning as well as the identification 
of suspicious areas. Note that MRI fusion was not used in the experiments reported in this paper, because it 
could interfere with the evaluation of the prostate tracking, which was our main objective. The fusion 
technique has, however been detailed in previous publications by our group 7, 21.  
As previously mentioned, this system has been described initially for a brachytherapy application. Indeed 
brachytherapy for low-risk localized prostate cancer is a standard of care, while results for focal therapy 
require more maturity. With this in mind, a dosimetry planning software taking into account the oblique 
directions of the needles is in process.  
The system could, also, be used for prostate transperineal biopsies, as the described system attempts, in 
general, to help the surgeon to perform accurate punctures in the operating room with the patient in a 
lithotomic position. Given that TRUS-MRI fusion is available on our system, it could be useful to perform 
multiparametric prostate biopsies. However, a transperineal approach would be required to use the robot. 
 The originality of the PROSPER robot is its ability to track prostate motions and deformations to correct 
the trajectories and depth of the needles22. During a manual procedure, especially in brachytherapy, these 
motions are suspected and the dosimetry plan is manually registered with the prostate shape. This study 
shows that these motions are not so easily noticeable and that positioning errors may occur also because of 
prostate rotation, which cannot be evaluated with classic US modalities.  
During a prostate brachytherapy procedure, such a robot might be clinically useful to correct for tissue 
deflection and deformation, adjust seed positions based on real-time dosimetry feedback and avoid the 
pubic arch so as to extend indications for large prostates.  Furthermore, a reduction of the number of 
needles required in the target volume could be enabled by inverse optimization to create more conformal 
treatment plans. 
These goals can be achieved by oblique needle insertions that require a robotic system. Indeed, manual 
insertion requires placing needles into areas according to the standard template holes.  
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Additionally the tracking system has the ability to make fine positional adjustments to offset distribution 
depending on gland motion. 
This robot, by providing a fusion between MRI images and an accurate 3D-TRUS guidance, could 
represent a future solution for robotic targeted focal therapy 1, 7, 23.  In the mean time, the system can be 
useful for performing more accurate robotic brachytherapy and prostate biopsies. 
The study has limitations. It can be considered as a first experience with this new robot. In the statistical 
analysis of our phantom experiments, it is important to keep in mind that the number of phantoms used was 
chosen empirically. 
 In our model, we did not consider the potential bleeding due to the needle insertion in vivo that can 
usually cause imaging artifacts, however, each needle inserted into the phantom left a prominent trace in the 
image, progressively degrading US image quality. This degradation did not affect the US registration 
algorithm, so we are confident that bleeding will not significantly affect system accuracy.  
An important future step for the furthered success of our prostate needle insertion system would be to 
determine the degree to which the prostate rotation occurs in vivo and to provide ways of mitigating this 
error, such as predicting the motion with biomechanical models or reducing prostate rotation with 
stabilizing needles24. 
Before using this system on human beings, preclinical studies on more realistic models are needed. These 
experiments encourage us to continue on with an in depth pre-clinical cadaver study. 
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CONCLUSION 
This robot for prostate focal therapy, brachytherapy and targeted prostate biopsies is the first system to use 
intraoperative prostate motion tracking to guide needles into the prostate. The preliminary experiments 
described show its ability to reach targets in spite of the motion of the prostate.  
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Figure 1:  Schematic representation: a- the PROSPER robot design, b- System setup  
 
 
 
 
Figure 2: (a) Test-bench setup showing all the components of our system (1: 3D endfire US probe, 2: 
prostate phantom, 3: US machine, 4: needle insertion module, 5: needle positioning module, 6: laboratory 
robot-probe stand).  (b) Photograph of our first robot prototype (7: vertical motors, 8: horizontal motors, 9: 
Z-translation motor, 10: homing Hall sensors, 11: needle disengagement mechanism, 12: needle insertion 
motor, 13: needle rotation motor, 14: needle grip, 15: needle, 16: robot end effector). 
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Figure 3: Glass bead implantation in a mobile and deformable phantom 
a- US view of the beads embedded inside the phantom with definition of a target 
b- CT scan showing the target hit by a glass bead 
 
 
 
 
 
Table 1: Distance errors between targets and beads stratified according to spatial location 
 
 # beads Distance error p Depth correction p 
Apex 50 2.28 (1.8-2.7) <0.001* 4.0 (3.0-5.6) <0.001* 
Base 40 3.83 (2.9-4.7)  6.5 (5.8-8.2)  
Center 28 2.6 (2.1-3.4) 0.002* 5.9 (3.1-6.9) 0.6 
Left 32 3.6 (2.7-4.8)  7.1 (3.4-11.2)  
Right 30 2.2 (1.8-2.9)  5.7 (3.8-9.5)  
Anterior 52 2.7 (2.1-3.6) 0.59 5.4 (3.1-6.7) 0.18 
Posterior 38 2.7 (2.1-3.9)  5.9(4.6- 6.8)  
Horizontal 67 2.7 (2.1-3.8) 0.28 5.4 (3.1-6.7) 0.18 
Angled 23 2.82 (1.8-3.3)  5.9(4.6- 6.8)  
Values are expressed as median (IQR). Unit is mm. 
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Table 2: Median distance of target movements along each axis showing mobility in all three directions and suggesting, not 
just prostate translation in the needle direction (z), but also prostate rotation. 
Results are expressed as median and IQR (mm) 
 
 x y z 
overall 
1.26 (0.57-
2.34) 
1.09 (0.51-
1.78) 
1.53 (0.89-
2.25) 
 
Apex 
1.10 (0.54-
1.81) 
0.73 (0.37-
1.47) 1.36 (0.7- 1.89) 
Base 2.1 (0.81-3.78) 1.49 (0.7-2.14) 2.0 (1.05- 2.57) 
Right 
 
0.97 (0.37-
1.31) 
0.89 (0.49-
1.53) 1.32 (0.7-2.0) 
Center 2.03 (1.20- 3.7) 
1.35 (0.55-
2.17) 1.59 (1.0- 2.6) 
Left 
2.13 (1.23-
3.77) 1.45 (0.57-2.3) 1.69 (1.03-2.4) 
Anterior 
 
1.1 (0.55-1.81) 0.73 (0.37-1.7) 1.36 (0.7-1.89) 
Posterio
r 1.62 (0.61-2.7) 1.09 (0.62-1.7) 
1.21 (0.69-
2.11) 
